<DOC>
	<DOCNO>NCT02852148</DOCNO>
	<brief_summary>The aim study evaluate participant report quality life , safety , overall performance ACTICOAT clinical setting . ACTICOAT silver coat antimicrobial barrier wound dress treatment variety wound type . It widely use routine clinical practice within UK . ACTICOAT CE mark use within intended indication use . The propose study require regulatory purpose . Primary Objective : To evaluate change health relate quality life , associate treatment . The primary outcome measure / endpoint change EQ-5D 5L mean single index utility score baseline 3 week . The study also seek gather report relevant safety performance data evaluate change , applicable , outcomes include : clinical sign symptoms infection ; wound length / width / depth ; wound heal measure ; tissue staining ; pain , adherence , pain application / removal ; wear time ; adverse event device deficiency . In total 25 participant recruit trial , comprise minimum 8 participant full partial thickness burn minimum 8 participant full partial thickness chronic wound . All participant wind dress use ACTICOAT , followed-up 3 week .</brief_summary>
	<brief_title>ACTICOAT™ Treatment Burns Chronic Wounds</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Burns</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<mesh_term>Pressure Ulcer</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>INCLUSION CRITERIA 1 . Must provide informed consent participate study . 2 . Eighteen ( 18 ) year age old . 3 . Males female . 4 . Able follow instruction deem capable complete EQ5D 5L Questionnaire appropriately . 5 . Willing able make require study visit , provide daytime telephone number contact directly . 6 . Presenting either chronic wound burn deem suitable treatment ACTICOAT meet either follow requirement : 1 . A full partial thickness chronic ( ≥ 4 week duration ) wound , consist Venous Leg Ulcer , Pressure Ulcer Diabetic Foot Ulcer , opinion Investigator , delegate SubInvestigator , appear infect base documented clinical sign symptom infection . 2 . A recently acquire ( ≤ 7 day ) noninfected burn , comprise full partial thickness wound , cover 2 % 18 % TBSA . Absence infection determine Investigator / SubInvestigator . EXCLUSION CRITERIA 1 . Contraindications hypersensitivity use test article , ancillary product component ( e.g. , know sensitivity silver ) . 2 . Participation treatment period another clinical trial within thirty ( 30 ) day Visit 1 . 3 . Treatment silver dressing ( i.e . non ACTICOAT dressing ) within seven ( 7 ) day Visit 1 . 4 . Patients skin feature opinion Investigator , interfere study assessment . 5 . Patients require concomitant use NPWT reference wound . 6 . Patients participate previously clinical trial heal withdrawn . 7 . Patients history poor compliance medical treatment . 8 . Patients , opinion Investigator , experience burn shock . 9 . Patients medical physical condition , opinion Investigator , would preclude safe subject participation study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Wound</keyword>
	<keyword>Pressure Ulcer</keyword>
	<keyword>Diabetic Foot Ulcer</keyword>
	<keyword>Venous Leg Ulcer</keyword>
	<keyword>Burn</keyword>
	<keyword>Quality Life</keyword>
</DOC>